Dose Response of Succinylcholine at the Adductor Pollicis of Children with Cerebral Palsy During Propofol and Nitrous Oxide Anesthesia
|
|
- Ruby Benson
- 5 years ago
- Views:
Transcription
1 PEDIATRIC ANESTHESIA SECTION EDITOR PAUL R. HICKEY Dose Response of Succinylcholine at the Adductor Pollicis of Children with Cerebral Palsy During Propofol and Nitrous Oxide Anesthesia Mary C. Theroux, MD, Barbara W. Brandom, MDt, Michael Zagnoev, MD*, Robert G. Kettrick, MD*, Freeman Miller, MD*, and Carmen Ponce, CRNA* Departments of Anesthesiology and Critical Care, *Alfred I. dupont Institute, Wilmington, Delaware, and tuniversity of Pittsburgh, Pittsburgh, Pennsylvania Children with cerebral palsy may be resistant to paralysis induced by nondepolarizing neuromuscular blocking drugs. Potency of a bolus of succinylcholine in children with cerebral palsy has not been studied previously. Therefore, we measured the response of the adductor pollicis to succinylcholine in children with cerebral palsy anesthetized with propofol and nitrous oxide. Forty children between the ages of 2 and 10.2 yr with spastic quadriplegic cerebral palsy were randomly assigned to receive 100,175,250, or 375 &kg of succinylcholine during anesthesia with propofol and nitrous oxide. The ulnar nerve was stimulated with a train-of-four supramaximal stimulus every 10 s and the compound electromyogram of the adductor pollicis recorded by a Datex NMT monitor. Plasma cholinesterase activity was measured in all patients with three different substrates (propionylthiocholine, benzoylcholine, and succinylcholine). Dibucaine number was also determined using inhibition of benzoylcholine degradation. ED,, of succinylcholine was pg/kg with 95% confidence intervals of pg/kg. ED,, of succinylcholine was pg with 95% confidence intervals of pg/kg. We conclude that children with cerebral palsy are slightly sensitive to succinylcholine, but probably not sufficiently to be clinically important. (Anesth Analg 1994;79:761-5) C erebral palsy is a group of disorders of movement and posture caused by a nonprogressive lesion of the developing brain (1). This is the most commonly occurring nervous system disorder in children. Etiology varies, but the characteristic feature remains the motor disorder. Spastic quadriplegia is the most common variety of cerebral palsy. The severity of motor dysfunction was classified into four groups by Evans and Alberman (2). Children with cerebral palsy have a higher incidence of gastroesophageal reflux and slower gastric emptying than normal children have (3). They also frequently drool as a result of decreased ability to clear pharyngeal secretions. Many anesthesiologists respond to the presence of these medical conditions Presented as an abstract at the American Society of Anesthesiologists meeting, Washington, Dc, 1993, and at the American Academy of Pediatrics meeting, Chicago, Accepted for publication June 10, Address correspondence and reprint requests to Mary C. Theroux, MD, c/o Editorial Services, Alfred I. dupont Institute, PO Box 269, Wilmington, DE by using a rapid sequence technique for induction of anesthesia and intubation of the trachea in these patients. Children with cerebral palsy are resistant to neuromuscular blockade induced by vecuronium (4). Resistance to nondepolarizing muscle relaxants in paretic upper extremities of patients with residual hemiplegia has been demonstrated (5,6). Although cerebral palsy in children often has been compared to adult onset upper motor neuron syndrome (7), there are many differences between the characteristics and distribution of signs. In cerebral palsy, instead of disuse, there is constant and repeated spasm of the extremities with dysfunctiona1 motion. This reflects the differing responses of the maturing nervous system to insult (8). Muscular denervation leads to extrajunctional proliferation of acetylcholine receptors which produces an increased response to succinylcholine and resistance to the effects of nondepolarizing relaxants (9,lO). This phenomenon is observed regularly in individuals who have suffered a stroke, have spinal cord injuries, or have an immobilized limb in a cast (9-17). If resistance to vecuronium in with palsy (4) is due to a change in function of the neuromuscular by the International Anesthesia Research Society /94/$5.00 Anesth Analg 1994;79:
2 762 PEDIATRIC ANESTHESIA THEROUX ET AL. ANESTH ANALG 1994; junction, such as proliferation of extrajunctional receptors, sensitivity to the paralytic effects of succinylcholine might be altered in these patients. However, children with cerebral palsy do not experience significant increase in plasma potassium after administration of succinylcholine as has been observed in adults with upper motor neuron disease (18). Potency of succinylcholine has not been documented in children with cerebral palsy. Therefore, we conducted a doseresponse study of succinylcholine using a single-dose technique in 40 children with spastic cerebral palsy. Methods After obtaining clinical research review committee approval and written informed consent from all patients or their parents, 40 ASA class I or I1 patients aged 2-10 yr were studied. All patients had spastic quadriplegic cerebral palsy with motor involvement of Class 3 or 4 (2). No patient was receiving anticonvulsants. Other exclusion criteria included a history of gastroesophageal reflux, aminoglycoside therapy, hepatic or renal insufficiency, or known electrolyte abnormalities. All patients were scheduled to undergo muscle or tendon releases or osteotomies. Patients received either oral or intranasal midazolam (oral, 500 pg/kg; intranasal, 200 pg/kg). The intranasal route was used when patients were uncooperative or otherwise unable to swallow oral medication. An intravenous (IV) catheter was placed when the patient was sedate and a blood sample was obtained for assay of plasma cholinesterase. Patients received pg/kg of atropine IV prior to induction of anesthesia and after blood was drawn for plasma cholinesterase assay. General anesthesia was induced with 2-4 mg/kg of propofol preceded by 1 mg/kg of lidocaine IV. Propofol infusion, pgkg-'.min-', with 60%- 70% nitrous oxide and oxygen maintained anesthesia. No volatile drugs were administered during the course of the study. Ventilation was controlled via mask and the patients' tracheas were intubated after administration of the second dose of succinylcholine when paralysis was complete. End-tidal carbon dioxide was maintained between 30 and 40 mm Hg. After induction of anesthesia, the palmar surface of the arm without the IV line was cleansed with alcohol and surface electrodes were placed over the ulnar nerve near the wrist and over the adductor pollicis muscle in the thenar eminence (19). Prior to administering succinylcholine, the ulnar nerve was stimulated supramaximally using a train-of-four stimulus at 10-s intervals. Two to three minutes of stable electromyogram (Datex, Helsinki, Finland) was obtained prior to administration of succinylcholine. Palmar temperature of the monitored hand and esophageal temperature were recorded. The first 30 patients received by random assignment either 175, 250, or 375 pg/kg of succinylcholine. A fourth dosage group, 100 pglkg, was added after the results from the first 15 patients showed the estimated ED50 to be lower than 175 pg/ kg. Succinylcholine was given at the hub of a "T" connector of a rapidly running IV infusion after a stable baseline was obtained 5-7 min after induction of anesthesia. When maximum response was obtained from the first dose, a second dose of 500 pg/kg was given to facilitate intubation. All patients achieved 100% depression of neuromuscular function after this dose. Plasma cholinesterase was determined using three different substrates. Propionylthiocholine is the substrate most commonly used (20), while benzoylcholine is preferred for genotyping (21). Since the drug of interest in our study was succinylcholine, we also examined the activity of plasma cholinesterase using succinylcholine as a substrate (22). Dibucaine number was also determined using inhibition of benzoylcholine degradation (23). Log transformation of the dose and probit transformation of the percent depression of neuromuscular function were performed. The dose-response data were examined for deviation from a linear relationship according to Finney (24). Because the data satisfied the assumption of linearity, linear regression of transformed data was performed by the method of least squares. Point estimates of EDso and ED9, were derived by inverse prediction and 95% confidence intervals were calculated for the potency estimates (25). Demographic and anesthetic variables of the four dosage groups were compared using analysis of variance. A P < 0.05 was considered statistically significant. The mean and SEM are presented. Results ED, of succinylcholine was pg/kg with 95% confidence intervals of pg/kg. ED,, of succinylcholine was pg/kg with 95% confidence intervals of pg/kg. The slope and intercept of the dose-response linear regression were (SE 0.77) and (SE 1.78), respectively (Fig. 1). Median and range values for maximum twitch depression and times to maximum block are shown in Table 1. The groups were comparable for age, weight, initial to final baseline difference in the electromyogram, and amount of propofol administered during induction and maintenance. No patient had a palmar temperature less than 33 C. All patients had plasma cholinesterase Ievels and dibucaine number within normal range. The plasma cholinesterase activity ranged from
3 ANESTH ANALG 1994:79:761-5 PEDIATRIC ANESTHESIA THEROUX ET AL. 763 Figure 1. Simple linear regression of log of the dose versus probit of the response (percent neuromuscular block). A A A slope= I" Intercept= , 1: R= log Dose Table 1. Onset Times and Neuromuscular Block (NMB) in the Four Dosage Groups Dosage groups (clg/kg) Time (s) to maximum NMB 45 (30-60) 55 (40-70) 55 (30-70) 60 (20-70) Maximum NMB (%) 18.3 (10-58) 54 ( ) 67 ( ) 93.8 (87-100) Values are median (range). 14 to 21 pmol.l-'*min-l with benzoylcholine as substrate, from 3063 to 6374 pmol.l-'-min-l using propionylthiocholine as substrate, and from 24 to 139 pmol-l-'.min-' using succinylcholine as substrate. No cardiovascular instability or suggestion of hyperkalemia was evident during the study. Discussion The dose-response relationship of succinylcholine in normal children has been studied by several investigators (26,27). One study (26) reported ED50 values of 228 pg/kg and 216 pg/kg and ED,, values of 445 pg/kg and 454 pg/kg for 1- to 4-yr and 5- to 10-yr age groups, respectively. Slopes of the dose-response linear regression reported in these studies were 5.7 and 5.1 for the two age groups mentioned. Another study (27), which examined neonates, infants, and children, reported ED50 of 184 pg/kg and ED90 of 352 pg/kg for the children ( yr), with significantly different ED values for neonates and infants. However, the weighted or common slope for the regression including all three age groups was 1.97 probits log-'. This slope is excessively shallow in comparison to other dose-response studies. Stimulus frequencies were the same for both studies mentioned above. Confidence intervals around point estimates of ED50 and ED,, were not reported in the previous studies. In comparing estimates of ED,, and ED,, from one study to another, variation in the data should be considered. Therefore, we produced 95% confidence intervals for our estimates of potency (28-31). Point estimates of the ED,, of succinylcholine reported in normal children in the above studies are higher than the upper limit of 95% confidence interval for the ED50 estimated from our study. Point estimates of the ED,, of succinylcholine in normal children, however, fall within the 95% confidence intervals of ED,, estimated from our study. Because the ED50 is estimated from doseresponse studies with narrower confidence intervals than is the ED,,, differences in relative potency will be more apparent if ED50 values are compared rather than ED,, values. Thus, we conclude that there is a statistically significant, but relatively small difference in the effects of succinylcholine on neuromuscular transmission between previously studied normal children and those with cerebral palsy in the present study. ED,, estimated from this study overlaps with ED,, estimated from normal children (26,27). Clinically, several times ED,, of succinylcholine is administered as a bolus for paralysis. Hence the difference in ED,, which we noted in comparison to previous studies of normal children is probably not clinically significant. In contrast to the relatively similar potency of succinylcholine in this study in children with cerebral palsy compared to children without cerebral palsy, vecuronium was significantly less potent (<50%) in children with cerebral palsy than in children without cerebral palsy (4). However, children with cerebral palsy in that study were also receiving anticonvulsant medications. The known interaction between anticonvulsants and muscle relaxants may have contributed to the resistance to vecuronium shown by the children with cerebral palsy in that study (32-35). Long-term phenytoin therapy causes significant change in acetylcholine receptor function and/or receptor number (32). Increased protein binding of nondepolarizing
4 764 PEDIATRIC ANESTHESIA THEROUX ET AL. ANESTH ANALG 1994; muscle relaxants is also documented under similar conditions (36). If changes in receptor properties resulting from cerebral palsy rather than from anticonvulsant medications caused resistance to vecuronium in the above-mentioned study, then it would be expected that patients with cerebral palsy would demonstrate sensitivity to succinylcholine. However, a previous study of children with cerebral palsy did not find evidence for greatly increased sensitivity to succinylcholine such as that which is present after denervation injury (18). The lower ED50 we observed in patients with cerebral palsy relative to historic controls was small and could have been due to methodologic differences between studies rather than physiologic differences between patients. Comparison with historic controls rather than concurrent controls is always problematic. Small differences in anesthetic or monitoring methods or unidentifiable differences between one population and another may produce small differences in estimates of potency. In this study, lidocaine may have enhanced the effects of succinylcholine. Unfortunately, it is unlikely that a normal concurrent control could be studied, owing to the recent contraindications placed on the use of succinylcholine during nonemergent anesthetics in normal children by the Food and Drug Administration. The constant state of spasticity in the skeletal muscles of children with cerebral palsy suggests that response to neuromuscular blockers might be different from normal children. The state of constant spasticity keeps the muscles and neuromuscular junctions in an exercised state. Exercise itself can change receptor properties causing sensitivity to nondepolarizing muscle relaxants (37). The children with cerebral palsy tend to be very thin morphologically because of difficulty in handling and swallowing food and higher energy expenditure due to spasticity. Dietary and exercise-related differences could contribute to differences in neuromuscular function (37,38). An increase in cholesterol content and change in sarcolemmal composition may contribute to changes in receptor properties as well (38). We conclude that the ED,, of succinylcholine determined in this study of children with Grades 3 and 4 cerebral palsy was less than reported previously for similarly aged normal children. However, ED,, values reported previously were within 95% confidence intervals determined in this study. Although there is a difference in the ED50 determined in our study, this is probably clinically insignificant when comparing clinical pharmacology of succinylcholine between normal children and those with cerebral palsy. References 1. Bax M. Terminology and classification of cerebral palsy. Dev Med Child Neurol 1964;6: Evans PM, Alberman E. Recording motor defects of children with cerebral palsy. Dev Med Child Neurol 1985; Mazzoleni S, Drigo P, DaDalt L, et al. Gastroesophageal reflux and infantile cerebral palsy: our experience and review of the literature. Pediatr Med Chir 1991;13: Moorthy SS, Krishna G, Dierdorf SF. Resistance to vecuronium in patients with cerebral palsy. Anesth Analg 1991;73: Graham DH. Monitoring neuromuscular block may be unreliable in patients with upper-motor-neuron lesions. Anesthesiol- ogy 1980;52: Moorthy SS, Hilgenberg JC. Resistance to non-depolarizing muscle relaxants in paretic upper extremities of patients with residual hemiplegia. Anesth Analg 1980;59: Lance JW. Symposium synopsis. In: Feldman RG, Young RR, Koella WP, eds. Spasticity: disordered motor control. Chicago: Year Book Publishers, Myklebust BM. A review of myotatic reflexes and the development of motor control and gait in infants and children: a special communication. Phys Ther 1990;70: Gronert GA. Disuse atrophy with resistance to pancuronium. Anesthesiology 1981;55: Holley FO. Relaxant resistant in disuse atrophy. Anesthesiology 1982:57: Martyn JA, White DA, Gronert GA, et al. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992;76: Fischbach GD, Robbins N. Effects of chronic disuse of rat soleus neuromuscular junction on postsynaptic membrane. J Neurophysiol 1971; Malathi S, Batmanabane M. Alterations in the morphology of the neuromuscular junction following experimental immobilization in cats. Experientia 1983;39: Robbins N, Fischbach GD. Effect of chronic disuse of rat soleus neuromuscular junctions on presynaptic functions. J Neurophysiol 1971 ;34: Pestronk A, Drachman DB, Griffin JW. Effect of muscle disuse on acetylcholine receptor. Nature 1976;260: Pestronk A, Drachman DB, Stanley EF, et al. Cholinergic transmission regulates extrajunctional acetylcholine receptors. Exp Neurol 1980;70: Carter JG, Sokoll MD, Gergis SD. Effect of spinal cord transection on neuromuscular junction in the rat. Anesthesiology 1981; 55: Dierdorf F, McNiece WL, Rao CC, et al. Effect of succinylcholine on plasma potassium in children with cerebral palsy. Anesthesiology 1985;62: Kalli I. Effect of surface electrode positioning on the compound action potential evoked by ulnar nerve stimulation in anaesthetized infants and children. Br J Anaesth 1989;62: Dietz AA, Rubinstein R, Lubrano T. Colorimetric determination of serum cholinesterase and its genetic variants by the Propionylthiochilone-Dithiobis (nitrobenzoic acid) procedure. Clin Chem 1973;19: Laine-Cessac P, Turcant A, Allain P. Automated determination of cholinesterase activity in plasma and erythrocytes by flowinjection analysis, and application to identify subjects sensitive to succinylcholine. Clin Chem 1989;35: Abernethy MH, George PM, Melton VE. A new succinylcholinebased assay of plasma cholinesterase. Clin Chem 1984;30: Kalow W, Genest K. A method for detection of atypical forms of serum cholinesterase. Determination of dibucaine numbers. Can J Biochem Physiol 1957;35: Finney DJ. Statistical method in biological assay. 3rd ed. London: Charles Griffin and Co., 1978: Neter J, Wasserman W, Kutner MH. Applied linear statistical models. Regression analysis of variance and experimental designs. 3rd ed. Homewood, IL: Irwin, 1990: Brown TC, Meretoja OA, Bell B, Clare B. Suxamethonium-electromyographic studies in children. Anaesth Intensive Care 1990; 18~473-6.
5 ANESTH ANALG PEDIATRIC ANESTHESIA THEROUX ET AL ; Meakin G, McKiernan EP, Morris P, Baker RD. Dose-response curve for suxamethonium in neonates, infants, and children. Br J Anaesth 1989;62: Braitman LE. Confidence intervals extract clinically useful information from data. Ann Intern Med 1988;108: Bulpitt CJ. Confidence intervals. Lancet 1987;1: Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 1986;292: Rothman KJ. A show of confidence. N Engl J Med 1978;299: Ornstein E, Matteo RS, Schwartz AE, et al. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology 1987; Ornstein E, Matteo RS, Young WL, Diaz J. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin. Anesthesiology 1985;63: Yaari Y, Pincus JH, Argov 2. Depression of synaptic transmission by diphenylhydantoin. Ann Neurol 1977;1: Roth S, Ebrahim ZY. Resistance to pancuronium in patients receiving carbamazepine. Anesthesiology 1987;66: Kim CS, Arnold FJ, Itani MS, Martyn AJ. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992; Gronert GA, White DA, Shafer SL, Matteo RS. Exercise produces sensitivity to metocurine. Anesthesiology 1989;70: DAlonzo AJ, McArdle JJ. Effects of 20,25-diazacholesterol treatment on the decay of endplate currents. Exp Neurol 1982;76:
Neuromuscular Junction
Muscle Relaxants Neuromuscular Junction Cholinergic antagonists Neuromuscular-blocking agents (mostly nicotinic antagonists): interfere with transmission of efferent impulses to skeletal muscles. These
More informationChapter 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
Chapter 18 Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) Uses of Neuromuscular Blocking Facilitate intubation Surgery Agents Enhance ventilator synchrony Reduce intracranial pressure (ICP)
More informationNEUROMUSCULAR BLOCKING AGENTS
NEUROMUSCULAR BLOCKING AGENTS Edward JN Ishac, Ph.D. Associate Professor, Pharmacology and Toxicology Smith 742, 828-2127, Email: eishac@vcu.edu Learning Objectives: 1. Understand the physiology of the
More informationNERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system
SYNAPTIC NERVOUS SYSTEM NERVOUS SYSTEM CENTRAL NERVOUS SYSTEM PERIPHERAL NERVOUS SYSTEM Brain Spinal Cord Autonomic nervous system Somatic nervous system Sympathetic nervous system Parasympathetic nervous
More informationEVALUATION OF ATRACURIUM NEUROMUSCULAR BLOCKADE IN PAEDIATRIC PATIENTS WITH BURN INJURY
Br. J. Anaesth. (1988), 60, 450-455 EVALUATION OF ATRACURIUM NEUROMUSCULAR BLOCKADE IN PAEDIATRIC PATIENTS WITH BURN INJURY A. K. MILLS AND J. A. J. MARTYN Depolarizing neuromuscular blocking drugs such
More informationA Nondepolarizing Neuromuscular Blocking (NMB) Agent
DOSING GUIDE A Nondepolarizing Neuromuscular Blocking (NMB) Agent Easy to remember dosing for the 0.20 mg/kg adult intubating doses of NIMBEX 1 *: For every 10 kg, give 1 ml of NIMBEX (2 mg/ml concentration)
More informationINTUBATING CONDITIONS AND INJECTION PAIN
INTUBATING CONDITIONS AND INJECTION PAIN - Cisatracurium or Rocuronium versus Rocuronium-Cisatracurium Combination - AHED ZEIDAN *, NAZIH NAHLE *, HILAL MAALIKI ** AND ANIS BARAKA *** Summary The present
More informationEffect of Vecuronium in different age group
Original Research Article Effect of Vecuronium in different age group Bharti Rajani 1, Hitesh Brahmbhatt 2, Hemlata Chaudhry 2, Hiren Parmar 3* 1 Associate Professor, Department of Anesthesiology, GMERS
More informationMUSCLE RELAXANTS. Mr. D.Raju, M.pharm, Lecturer
MUSCLE RELAXANTS Mr. D.Raju, M.pharm, Lecturer Muscle Relaxants are classified as: I)Peripherally acting A.Neuromuscular blocking agents:- 1) Depolarizing muscle relaxants. 2) Non-depolarizing muscle relaxants
More informationChapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise
Chapter 18 Neuromuscular Blocking Agents Study Guide and Application Exercise 1. Read chapter 2. Review objectives (p.305) 3. Review key terms and definitions (p.305) Add: Cholinesterase inhibitor Vagal
More informationFOR REPRESENTATIVE EDUCATION
Neuromuscular Blockade in the ICU NIMBEX Indication 1 NIMBEX (cisatracurium besylate) is indicated as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients
More informationHST-151 Clinical Pharmacology in the Operating Room
Harvard-MIT Division of Health Sciences and Technology HST.151: Principles of Pharmocology Instructors: Dr. Carl Rosow, Dr. David Standaert and Prof. Gary Strichartz 1 HST-151 Clinical Pharmacology in
More informationreceptors determines clinical symptoms of the patients and modulates the sensitivity to nondepolarizing neuromuscular
346 Anesthesiology 2000; 93:346 50 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Preanesthetic Train-of-four Fade Predicts the Atracurium Requirement of Myasthenia
More informationThe effect of desflurane on rocuronium onset, clinical duration and maintenance requirements
(Acta Anaesth. Belg., 2006, 57, 349-353) The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements R. G. STOUT (*), T. J. GAN (**), P. S. A. GLASS (***), D. G. SILVERMAN
More informationNeuromuscular Blockers
Neuromuscular Blockers Joanne Leung joanneleung22@hotmail.com Oct 14, 2014 Objectives After this lecture, you should be able to: Describe the physiology of the neuromuscular junction Differentiate the
More informationUpdated review of resistance to neuromuscular blocking agents
Anesth Pain Med 2018;13:122-127 https://doi.org/10.17085/apm.2018.13.2.122 pissn 1975-5171 ㆍ eissn 2383-7977 Review Received October 24, 2017 Revised November 21, 2017 Accepted November 21, 2017 Updated
More informationPOTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE
Br.J. Anaesth. (987), 9, 0-06 POTENTIATION OF THE NEUROMUSCULAR BLOCKADE PRODUCED BY ALCURONIUM WITH HALOTHANE, ENFLURANE AND ISOFLURANE S. J. KEENS, J. M. HUNTER, S. L. SNOWDON AND J. E. UTTING Volatile
More informationPRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN
British Journal of Anaesthesia 1990; 64: 577-581 PRETREATMENT WITH NON-DEPOLARIZING NEUROMUSCULAR BLOCKING AGENTS AND SUXAMETHONIUM-INDUCED INCREASES IN RESTING JAW TENSION IN CHILDREN C. E. SMITH, J.
More informationPOST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS
Br. J. Anaesth. (9), 60, 3-35 POST-TETANIC COUNT AND PROFOUND NEUROMUSCULAR BLOCKADE WITH ATRACURIUM INFUSION IN PAEDIATRIC PATIENTS S. A. RIDLEY AND D. J. HATCH Atracurium degrades rapidly and, because
More informationPharmacology of the Neuromuscular Junction (NMJ)
Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationBenztropine and trihexyphenidyl: Centrally acting antimuscarinic agents used for treatment of Parkinson disease & extrapyramidal symptoms.
Scopolamine: Tertiary amine plant alkaloid. Produces peripheral effects similar to those of atropine. Unlike atropine, scopolamine has greater action on the CNS (observed at therapeutic doses). It has
More informationAnesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists. Upon completion of this activity, participants will be better able to:
Anesthesia and Neuromuscular Blockade: A Guide for Hospital Pharmacists EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Understand the use of neuromuscular
More informationSOMATIC AND AUTONOMIC UPREGULATION IN THE QUADRIPLEGIC PATIENT
EDITORIAL SOMATIC AND AUTONOMIC UPREGULATION IN THE QUADRIPLEGIC PATIENT Patients with chronic spinal cord transection develop both somatic and autonomic denervation below the level of denervation. This
More informationNeuromuscular Monitoring and Patient Safety:
Neuromuscular Monitoring and Patient Safety: Pulmonary Complications of Residual Block CEEA Course Tuesday, Sept 4, 2012 Târgu Mureş, Romania Sorin J. Brull, MD, FCARCSI (Hon) Editor, Patient Safety Section
More informationSkeletal Muscle Relaxants. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014
Skeletal Muscle Relaxants Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan March, 2014 The nicotinic Acetycholine receptor Present at the neuromuscular junction, peripheral
More informationPharmacology of the Neuromuscular Junction (NMJ)
Pharmacology of the Neuromuscular Junction (NMJ) Edward JN Ishac, Ph.D. Professor Smith Building, Room 742 eishac@vcu.edu 828 2127 Department of Pharmacology and Toxicology Medical College of Virginia
More informationSuccinycholine: Succinylcholine has no place in pediatric anesthesia. Wads Ames MBBS FRCA
Succinycholine: Succinylcholine has no place in pediatric anesthesia Wads Ames MBBS FRCA Food And Drug Administration Created in 1906 Responsible for protecting and promoting public health through the
More information200 mg/20 ml (10 mg/ml) in single-dose vials (3)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NIMBEX safely and effectively. See full prescribing information for NIMBEX. NIMBEX (cisatracurium
More informationA defasciculating dose of d-tubocurarine causes resistance to succinylcholine
538 A defasciculating dose of d-tubocurarine causes resistance to succinylcholine James B. Eisenkraft MO MRCP FFARCS, Melinda L. Mingus io, Andrew Herlich DMI~ MD, W. Jeffrey Book MO FRCPC, Aaron F. Kopman
More informationCholinergic antagonists
Cholinergic antagonists Cholinergic antagonists: They are also called anticholinergic drugs or cholinergic blockers, this group include: 1.Antimuscarinic agents ( atropine, ipratropium, scopolamine) 2.
More informationComparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients
British Journal of Clinical Pharmacology DOI:1.1111/j.1365-2125.21.383.x Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients Simone van Kralingen,
More informationCOMPARISON OF INTUBATING CONDITIONS OF SUCCINYLCHOLINE WITH THAT OF ROCURONIUM
COMPARISON OF INTUBATING CONDITIONS OF SUCCINYLCHOLINE WITH THAT OF ROCURONIUM *Lata D. Shetty Department of Anaesthesiology, Khaja Banda Nawaz Institute of Medical Sciences Gulbarga, Karnataka, India
More informationUniversity of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation
University of Mississippi Medical Center University of Mississippi Health Care Pharmacy and Therapeutics Committee Medication Use Evaluation Cisatracurium (Nimbex ) and Vecuronium (Norcuron ) PURPOSE The
More informationAnaesthetic Plan And The Practical Conduct Of Anaesthesia. Dr.S.Vashisht Hillingdon Hospital
Anaesthetic Plan And The Practical Conduct Of Anaesthesia Dr.S.Vashisht Hillingdon Hospital Anaesthetic Plan Is based on Age / physiological status of the patient (ASA) Co-morbid conditions that may be
More informationOnset of action and intubating conditions after administration of rocuronium or mivacurium in children
79 Onset of action and intubating conditions after administration of rocuronium or mivacurium in children Papagiannopoulou Pinelopi, Sfyra Evaggelia, Georgiou Mary, Georgiadou Theodora, Kanakoudis Fotios
More informationPRODUCT MONOGRAPH. Solution for Injection 20 mg/10 ml (2 mg/ml) Cisatracurium. Non-depolarizing Skeletal Neuromuscular Blocking Agent
PRODUCT MONOGRAPH Pr CISATRACURIUM BESYLATE INJECTION Solution for Injection 20 mg/10 ml (2 mg/ml) Cisatracurium Non-depolarizing Skeletal Neuromuscular Blocking Agent This drug should be administered
More informationRunning head: SUGAMMADEX AND MYASTHENIA GRAVIS 1
Running head: SUGAMMADEX AND MYASTHENIA GRAVIS 1 Sugammadex in Patients with Myasthenia Gravis Jennifer A. Madsen University of Kansas SUGAMMADEX AND MYASTHENIA GRAVIS 2 Title of Proposed Research Project
More informationTRANSPARENCY COMMITTEE OPINION. 21 January 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 January 2009 BRIDION 100 mg/ml, solution for injection Box containing 10 x 2 ml bottles, CIP: 573 553-9 Box containing
More informationComparison of continuous infusion and intermittent bolus administration of Cisatracurium in cardiac surgery: a randomized clinical trial
Original Article Comparison of continuous infusion and intermittent bolus administration of Cisatracurium in cardiac surgery: a randomized clinical trial Moosa Mirinejad, Ali Reza Yaghoubi, Rasoul Azarfarin,
More informationThe Neuromuscular Effects and Tracheal Intubation Conditions After Small Doses of Succinylcholine
The Neuromuscular Effects and Tracheal Intubation Conditions After Small Doses of Succinylcholine Mohammad I. El-Orbany, MD, Ninos J. Joseph, BS, M. Ramez Salem, MD, and Arthur J. Klowden, MD Department
More informationCISATRACURIUM IN CARDIAC SURGERY
CISATRACURIUM IN CARDIAC SURGERY - Continuous Infusion vs. Bolus Administration - MOOSA MIRINEJAD *, RASOUL AZARFARIN * AND AZIN ALIZADEH ASL * Abstract The aim of this study was the comparison of infusion
More informationPAEDIATRIC ANAESTHETIC EMERGENCIES PART I. Dr James Cockcroft, South West School of Anaesthesia. Dr Sarah Rawlinson, Derriford Hospital, Plymouth, UK
PAEDIATRIC ANAESTHETIC EMERGENCIES PART I Original Article by: Dr Claire Todd, South West School of Anaesthesia Dr James Cockcroft, South West School of Anaesthesia Dr Sarah Rawlinson, Derriford Hospital,
More informationThe Latest Approaches to Reversal of Neuromuscular Blocking Agents
The Latest Approaches to Reversal of Neuromuscular Blocking Agents Janay Bailey, Pharm.D. Anesthesiology 2017; 126:173-90 Objectives Pharmacists Determine optimal paralytic choices in knowing if reversal
More information(PP XI) Dr. Samir Matloob
DRUGS ACTING ON THE CHOLINERGIC SYSTEM AND THE NEUROMUSCULAR BLOCKING DRUGS IV (NICOTINIC ANTAGONISTS) (PP XI) Dr. Samir Matloob Dept. of Pharmacology Baghdad College of Medicine Drugs acting on the cholinergic
More informationPOST-TETANIC COUNT AND INTENSE NEUROMUSCULAR BLOCKADE WITH VECURONIUM IN CHILDREN
Br. J. Anaesth. (988), 6, 55-556 POST-TETANIC COUNT AND INTENSE NEUROMUSCULAR BLOCKADE WITH VECURONIUM IN CHILDREN S. A. RIDLEY AND N. BRAUDE Monitoring of profound neuromuscular blockade may be based
More informationNEOSTIGMINE VERSUS SUGAMMADEX FOR REVERSAL OF NEUROMUSCULAR BLOCK
EDITORIAL NEOSTIGMINE VERSUS SUGAMMADEX FOR REVERSAL OF NEUROMUSCULAR BLOCK Neostigmine is the classic acetylcholinesterase antagonist, which is widely used for reversal of neuromuscular block of all nondepolarising
More informationTracheal intubation in children after induction of anesthesia with propofol and remifentanil without a muscle relaxant
Original Article Tracheal intubation in children after induction of anesthesia with propofol and remifentanil without a muscle relaxant Mirmohammad Taghi Mortazavi, 1 Masood Parish, 1 Naghi Abedini, 2
More information*Author for Correspondence
COMPARATIVE EVALUATION OF ONSET TIME INTUBATING CONDITION JUDGED BY CLINICAL CRITERIA AND HAEMODYNAMIC RESPONSE AFTER THE INTUBATING DOSE OF ROCURONIUM AND VECURONIUM *Namita Gupta 1, Mamta Sharma 2, Pusplata
More informationSEDATION FOR SMALL PROCEDURES
SEDATION FOR SMALL PROCEDURES Sinno Simons Erasmus MC Sophia Children s Hospital Rotterdam, the Netherlands s.simons@erasmusmc.nl SEDATION in newborns How and when How to evaluate How to dose Why to use
More informationBIS Monitoring. ASSESSMENT OF DEPTH OF ANAESTHESIA. Why measure depth of anaesthesia? or how to avoid. awareness in one easy lesson
BIS Monitoring or how to avoid www.eurosiva.org awareness in one easy lesson ASSESSMENT MONITORING ANAESTHETIC DEPTH OF DEPTH OF ANAESTHESIA Why measure depth of anaesthesia? How do the various EEG monitors
More informationAnesthetic concerns when paralyzing is not an option. By: Ashley Evick, BSN, SRNA
Anesthetic concerns when paralyzing is not an option By: Ashley Evick, BSN, SRNA Introduction Neuromuscular blockade is utilized in many of the surgeries performed today. There are two types of neuromuscular
More informationCHAPTER 11. General and Local Anesthetics. Anesthetics. Anesthesia. Eliza Rivera-Mitu, RN, MSN NDEG 26 A
CHAPTER 11 General and Local Anesthetics Eliza Rivera-Mitu, RN, MSN NDEG 26 A Anesthetics Agents that depress the central nervous system (CNS) Depression of consciousness Loss of responsiveness to sensory
More informationDETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES
British Journal of Anaesthesia 1991; 66: 469-45 DETERMINANTS OF THE REVERSAL TIME OF COMPETITIVE NEUROMUSCULAR BLOCK BY ANTICHOLINESTERASES G. H. BEEMER, A. R. BJORKSTEN, P. J. DAWSON, R. J. DAWSON, P.
More informationMonitoring of neuromuscular block Conor D McGrath BSc(Hons) MB ChB FRCA
Conor D McGrath BSc(Hons) MB ChB FRCA Jennifer M Hunter MB ChB PHD FRCA There is increasing evidence that residual neuromuscular block is common, and also that it may adversely affect patient outcome.
More informationThe Effect of Bispectral Index Monitoring on Anesthetic Use and Recovery in Children Anesthetized with Sevoflurane in Nitrous Oxide
PEDIATRIC ANESTHESIA SECTION EDITOR WILLIAM J. GREELEY SOCIETY FOR PEDIATRIC ANESTHESIA The Effect of Bispectral Index Monitoring on Anesthetic Use and Recovery in Children Anesthetized with Sevoflurane
More informationEVALUATION OF INTUBATING CONDITIONS WITH AND WITHOUT PRIMING DOSE OF ROCURONIUM BROMIDE
EVALUATION OF INTUBATING CONDITIONS WITH AND WITHOUT PRIMING DOSE OF ROCURONIUM BROMIDE Revathy Jeevarathnam 1, Balasubramaniam Solaiappan 2 1Professor, Department of Anaesthesiology, Chengalpattu Medical
More informationNondepolarizing Neuromuscular Blocking Agents in the Elderly: Dosing Paradigms Revisited Cynthia A. Lien, M.D.
Nondepolarizing Neuromuscular Blocking Agents in the Elderly: Dosing Paradigms Revisited Cynthia A. Lien, M.D. Introduction Estimates are that by the year 2050, the percentage of people in the United States
More informationNIMBEX (cisatracurium besylate) injection
NIMBEX (cisatracurium besylate) injection This drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards. NOT FOR USE IN NEONATES CONTAINS
More informationUse of the Intubating Laryngeal Mask Airway
340 Anesthesiology 2000; 93:340 5 2000 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Use of the Intubating Laryngeal Mask Airway Are Muscle Relaxants Necessary? Janet
More informationMaterials and Methods
Anesthesiology 2002; 97:616 21 2002 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Duration of Anesthesia before Muscle Relaxant Injection Influences Level of Paralysis
More informationJoseph F. Answine, MD
Joseph F. Answine, MD Joseph F. Answine, MD Staff Anesthesiologist Pinnacle Health Hospitals Harrisburg, PA Clinical Associate Professor of Anesthesiology Pennsylvania State University Hospital Reversal
More informationEffect of Magnesium Sulphate on the Speed of Onset and Duration of Neuromuscular Block Produced by Rocuronium Bromide
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 2 Ver. VI (February. 2017), PP 54-58 www.iosrjournals.org Effect of Magnesium Sulphate on the
More informationNIMBEX Injection. This information is intended for U.S. residents only. only. (cisatracurium besylate)
This information is intended for U.S. residents only. NIMBEX Injection (cisatracurium besylate) only DESCRIPTION CLINICAL PHARMACOLOGY INDICATIONS AND USAGE CONTRAINDICATIONS WARNINGS PRECAUTIONS ADVERSE
More informationGeneral anesthesia. No single drug capable of achieving these effects both safely and effectively.
General anesthesia General anesthesia is essential to surgical practice, because it renders patients analgesic, amnesia, and unconscious reflexes, while causing muscle relaxation and suppression of undesirable
More informationComparison between the Clinical Assessment, Peripheral Nerve Stimulation (PNS), and Acceleromyography (AMG) to Reverse Neuromuscular Blockade
PERIPHERAL THE IRAQI POSTGRADUATE NERVE STIMULATION MEDICAL JOURNAL Comparison between the Clinical Assessment, Peripheral Nerve Stimulation (PNS), and Acceleromyography (AMG) to Reverse Neuromuscular
More informationBETA-ADRENOCEPTOR BLOCKADE, ALPHA-STIMULATION AND CHANGES IN PLASMA POTASSIUM CONCENTRATION AFTER SUXAMETHONIUM ADMINISTRATION IN DOGSf
Br.J. Anaesth. (987), 59, 6-66 BETA-ADRENOCEPTOR BLOCKADE, ALPHA-STIMULATION AND CHANGES IN PLASMA POTASSIUM CONCENTRATION AFTER SUXAMETHONIUM ADMINISTRATION IN DOGSf D. R. GOLDHILL, J. A. J. MARTYN AND
More informationPMT. Explain the importance of reflex actions (3) Page 1 of 19
Q1. When a finger accidentally touches a hot object, a reflex action occurs. The biceps muscle contracts, causing the arm to be flexed and the finger is pulled away. The diagram shows the arrangement of
More informationLESSON ASSIGNMENT. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant.
LESSON ASSIGNMENT LESSON 3 Skeletal Muscle Relaxants. TEXT ASSIGNMENT Paragraphs 3-1 through 3-7. LESSON OBJECTIVES 3-1. Given a group of definitions, select the definition of the term muscle relaxant.
More informationMaterials and Methods
Anesthesiology 2001; 95:96 101 2001 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. The Corrugator Supercilii, Not the Orbicularis Oculi, Reflects Rocuronium Neuromuscular
More informationOriginal Article Age and the neuromuscular blockading effects of cisatracurium
Int J Clin Exp Med 2015;8(9):16664-16669 www.ijcem.com /ISSN:1940-5901/IJCEM0011802 Original Article Age and the neuromuscular blockading effects of cisatracurium Jianrong Guo 1, Xiaofang Zhou 1, Xiaohong
More informationEvaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric patients
Original Article Evaluation of intubation condition following administration of rocuronium in comparison to atracurium in paediatric Abdul Kuddus Khan 1*, MM Abdul Wadud 2, Azizul Gafur 3, Rafayetullah
More informationNeuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxideisoflurane
641 Won W. Choi MD, Mahesh P. Mehta MD, David J. Murray MI), Martin D. Sokoll MD, Robert B. Forbes MD, Samir D. Gergis MD, Martha Abou-Donia phd,jerry Kirchner BA Neuromuscular and cardiovascular effects
More informationMonitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus
British Journal of Anaesthesia 90 (4): 480±6 (2003) DOI: 10.1093/bja/aeg089 Monitoring of neuromuscular block after administration of vecuronium in patients with diabetes mellitus Y. Saitoh 1 *, K. Kaneda
More informationComparison Of Plasma Cholinesterase Levels And The Duration Of Suxamethonium Apnoea In Nigerian Adult And Paediatric Patients
ISPUB.COM The Internet Journal of Anesthesiology Volume 30 Number 2 Comparison Of Plasma Cholinesterase Levels And The Duration Of Suxamethonium Apnoea In Nigerian Adult And Paediatric Patients A OO, D
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Solution for Injection CZ/H/PSUR/0005/002 Date of FAR:
Core Safety Profile Active substance: Rocuronium bromide Pharmaceutical form(s)/strength: Solution for Injection P-RMS: CZ/H/PSUR/0005/002 Date of FAR: 31.05.2012 4.3 Contraindications Hypersensitivity
More informationBritish Journal ofanaesthesia 85 (2): (2000)
British Journal ofanaesthesia 85 (2): 251-5 (2000) Comparison of succinylcholine with two doses of rocuronium using a new method of monitoring neuromuscular block at the laryngeal muscles by surface laryngeal
More informationRELATIONSHIP BETWEEN SUCCINYLCHOLINE INDUCED APNEA AND DIBUCAINE NUMBER IN PATIENTS WITH GENETIC DEFICIENCY OF PLASMA CHOLINESTERASE
Vo1wne II Nwnber 2 Summer 1376 August 1997 RELATIONSHIP BETWEEN SUCCINYLCHOLINE INDUCED APNEA AND DIBUCAINE NUMBER IN PATIENTS WITH GENETIC DEFICIENCY OF PLASMA CHOLINESTERASE MAHINDUKHT KEYHANI, Ph.D.,
More informationPHARMACODYNAMICS OF MIVACURIUM CHLORIDE IN PATIENTS WITH HEPATIC CIRRHOSIS
British Journal of Anaesthesia 1993; 71: 227-231 PHARMACODYNAMICS OF MIVACURIUM CHLORIDE IN PATIENTS WITH HEPATIC CIRRHOSIS J. C. DEVLIN, A. G. HEAD-RAPSON, C. J. R. PARKER AND J. M. HUNTER SUMMARY Ten
More informationThe cholinesterase inhibitors, neostigmine and edrophonium,
Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Glycopyrrolate and Atropine Ozlem Sacan, MD Paul F. White, MD, PhD Burcu Tufanogullari, MD Kevin Klein, MD BACKGROUND: is a modified
More informationGanglion blocking agents
Ganglion blocking agents -out of date -Specifically act on the nicotinic receptors of both parasymphatetic and sympathetic ganglia - no selectivity toward PG or SG -These drugs are non-depolarizing, competitive
More informationNeuromuscular Efficacy and Histamine-Release Hemodynamic Changes Produced by Rocuronium versus Atracurium: A Comparative Study
Journal of the Egyptian Nat. Cancer Inst., Vol. 16, No. 2, June: 17-113, 24 Neuromuscular Efficacy and Histamine-Release Hemodynamic Changes Produced by Rocuronium versus Atracurium: A Comparative Study
More informationANESTHESIA EXAM (four week rotation)
SPARROW HEALTH SYSTEM ANESTHESIA SERVICES ANESTHESIA EXAM (four week rotation) Circle the best answer 1. During spontaneous breathing, volatile anesthetics A. Increase tidal volume and decrease respiratory
More informationVECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION
Br. J. Anaesth. (1985), 57, 765-769 VECURONIUM BROMIDE IN ANAESTHESIA FOR LAPAROSCOPIC STERILIZATION J. E. CALDWELL, J. M. BRAIDWOOD AND D. S. SIMPSON Although artificial ventilation can be used to avoid
More informationUse of the depolarizing neuromuscular blocker
Prolonged Neuromuscular Block in a 74-Year- Old Patient Allen Branch, CRNA, MS John Rafacz, CRNA, MS Lisa Boudreaux, RN, MS, CCRN Pseudocholinesterase abnormalities are an inherited trait, which causes
More informationThis drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards.
MIVACRON Injection (mivacurium chloride) This drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards. DESCRIPTION MIVACRON (mivacurium
More informationPediatric Anesthesia Historical Perspective 573 Andrew T. Costarino, Jr and John J. Downes
PEDIATRIC ANESTHESIOLOGY Foreword Lee A. Fleisher xiii Preface Andrew T. Costarino, Jr and B. Randall Brenn xv Pediatric Anesthesia Historical Perspective 573 Andrew T. Costarino, Jr and John J. Downes
More informationGuide to Neuromuscular Blocking Agents
Guide to Neuromuscular Blocking Agents EMILY STERLING, PHARMD Associate Clinical Instructor University of Washington School of Pharmacy Seattle, Washington P. SHANE WINSTEAD, PHARMD ICU Clinical Pharmacy
More informationAntagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia
British Journal of Anaesthesia 94 (6): 742 7 (2005) doi:10.1093/bja/aei120 Advance Access publication March 18, 2005 Antagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia
More informationType of intervention Anaesthesia. Economic study type Cost-effectiveness analysis.
Comparison of the costs and recovery profiles of three anesthetic techniques for ambulatory anorectal surgery Li S T, Coloma M, White P F, Watcha M F, Chiu J W, Li H, Huber P J Record Status This is a
More informationENDOTRACHEAL INTUBATION POLICY
POLICY Indications: Ineffective ventilation with mask and t-piece, or mask and bag technique Inability to maintain a patent airway Need or anticipation of need for prolonged ventilation Need for endotracheal
More informationDISORDERS OF THE NERVOUS SYSTEM
DISORDERS OF THE NERVOUS SYSTEM Bell Work What s your reaction time? Go to this website and check it out: https://www.justpark.com/creative/reaction-timetest/ Read the following brief article and summarize
More informationInfluence of muscle relaxation on neuromonitoring of the recurrent laryngeal nerve during thyroid surgery
British Journal of Anaesthesia 94 (5): 596 600 (2005) doi:10.1093/bja/aei110 Advance Access publication February 25, 2005 Influence of muscle relaxation on neuromonitoring of the recurrent laryngeal nerve
More informationBOTULINUM TOXIN AND INTRATHECAL BACLOFEN. Spencer Cotterell DO Mercy Rehabilitation Hospital June 30, 2018
BOTULINUM TOXIN AND INTRATHECAL BACLOFEN Spencer Cotterell DO Mercy Rehabilitation Hospital June 30, 2018 INJECTABLES MEDICAL MANAGEMENT OF SPASTICITY Leonard, J In: Botulinum toxin: 2009 A protein and
More informationIntraoperative neurophysiological monitoring for the anaesthetist
Intraoperative neurophysiological monitoring for the anaesthetist Part 2: A review of anaesthesia and its implications for intraoperative neurophysiological monitoring Abstract Van Der Walt JJN, MBChB,
More informationMay 2013 Anesthetics SLOs Page 1 of 5
May 2013 Anesthetics SLOs Page 1 of 5 1. A client is having a scalp laceration sutured and is to be given Lidocaine that contains Epinephrine. The nurse knows that this combination is desgined to: A. Cause
More informationComparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases)
ISPUB.COM The Internet Journal of Anesthesiology Volume 20 Number 1 Comparative study of intubating conditions after Rocuronium and Suxamethonium (study of 80 cases) K Bhati, V Parmar Citation K Bhati,
More informationIntroduction Corresponding author:
Anesthetic Management Of Aortic Valve Replacement In A Myasthenia Gravis Patient, The Era Of A New Reversal Alia S. Dabbous 1*, Patricia W Nehme 1 and Ahmad M Abou Leila 2 A 66 year old man diagnosed with
More informationEFFECT OF IONIZED CALCIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF ATRACURIUM AND VECURONIUM IN THE CAT
British Journal of Anaesthesia 199; 64: 199-26 EFFECT OF IONIZED CALCIUM ON THE NEUROMUSCULAR BLOCKING ACTIONS OF ATRACURIUM AND VECURONIUM IN THE CAT L. GRAMSTAD AND E. S. HYSING SUMMARY We have determined
More informationXiaochong Fan, Minyu Ma, Zhisong Li, Shengkai Gong, Wei Zhang, Yuanyuan Wen
Int J Clin Exp Med 2015;8(9):16369-16373 www.ijcem.com /ISSN:1940-5901/IJCEM0008198 Original Article The relationship between the target effective site concentration of rocuronium and the degree of recovery
More information